Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, deadlines, and what-not has predictably returned. But what can you do? The world keeps spinning, after all. So to cope, yes, we are in the Pharmalot cafeteria brewing cups of stimulation. Our choice today is cinnamon dolce, for those tracking this sort of thing. Meanwhile, here are some fresh tidbits for you to devour. We hope you have a smashing day and do keep in touch.

White House trade advisor Peter Navarro advocated for bringing home more of the U.S. pharmaceutical supply chain amid the coronavirus in China, Fox Business reports. “We’ve off-shored far too much of our supply chain, not just for corona, but also for the essential medicines we need. Same reasons we off-shored a lot of our other stuff: it’s a cheap labor environment, lax environment, and most of all, unfair trade practices. … On the supply chain issue, for the American people they need to understand that in crises like this we have no allies.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy